Showing 1 - 11 results of 11 for search 'Ágnes Milassin', query time: 0.04s Refine Results
  1. 1
    Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective

    Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective by Ágnes Milassin, Anna Fábián, Tamás Molnár

    Published 2019-04-01
    Get full text
    Article
  2. 2
    Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas

    Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas by Renáta Bor, Anna Fábián, Anita Bálint, Klaudia Farkas, Mónika Szűcs, Ágnes Milassin, László Czakó, Mariann Rutka, Tamás Molnár, Zoltán Szepes

    Published 2017-08-01
    Get full text
    Article
  3. 3
    Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.

    Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease. by Renáta Bor, Klaudia Farkas, Anna Fábián, Anita Bálint, Ágnes Milassin, Mariann Rutka, Mária Matuz, Ferenc Nagy, Zoltán Szepes, Tamás Molnár

    Published 2017-01-01
    Get full text
    Article
  4. 4
    How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system

    How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system by Anita Bálint, Klaudia Farkas, Zoltán Szepes, Ferenc Nagy, Mónika Szűcs, László Tiszlavicz, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián, Tamás Molnár

    Published 2018-01-01
    Get full text
    Article
  5. 5
    Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.

    Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. by Kata Szántó, Tibor Nyári, Anita Bálint, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Klaudia Farkas

    Published 2018-01-01
    Get full text
    Article
  6. 6
    Comparison of therapeutic efficacy and treatment costs of self-expandable metal stents and plastic stents for management of malignant biliary obstruction

    Comparison of therapeutic efficacy and treatment costs of self-expandable metal stents and plastic stents for management of malignant biliary obstruction by Renáta Bor, Anna Fábián, Mónika Szűcs, Anita Bálint, Mariann Rutka, Tibor Tóth, László Czakó, Klaudia Farkas, Norbert Buzás, Ágnes Milassin, Tamás Molnár, Zoltán Szepes

    Published 2023-02-01
    Get full text
    Article
  7. 7
    Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study.

    Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study. by Péter Kunovszki, Ágnes Milassin, Judit Gimesi-Országh, Péter Takács, Kata Szántó, Anita Bálint, Klaudia Farkas, András Borsi, Péter L Lakatos, Tamás Szamosi, Tamás Molnár

    Published 2020-01-01
    Get full text
    Article
  8. 8
    Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohn’s disease—A multicenter “real life” study

    Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohn’s disease—A multicenter “real life” study by Anita Bálint, Dalma Törőcsik, Károly Palatka, Zoltán Szepes, Mónika Szűcs, Ferenci Tamás, Ferenc Nagy, Klaudia Farkas, Anna Fábián, Renáta Bor, Ágnes Milassin, Mariann Rutka, Tamás Molnár

    Published 2016-12-01
    Get full text
    Article
  9. 9
    Effect of COVID-19 pandemic on workflows and infection prevention strategies of endoscopy units in Hungary: a cross-sectional survey

    Effect of COVID-19 pandemic on workflows and infection prevention strategies of endoscopy units in Hungary: a cross-sectional survey by Renáta Bor, Kata Judit Szántó, Anna Fábián, Klaudia Farkas, Mónika Szűcs, Mariann Rutka, Tibor Tóth, Anita Bálint, Ágnes Milassin, Zsolt Dubravcsik, Hungarian GI Endoscopy COVID-19 Study Group, Zoltán Szepes, Tamás Molnár

    Published 2021-03-01
    Get full text
    Article
  10. 10
    Ustekinumab is associated with superior treatment persistence but not with higher remission rates vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

    Ustekinumab is associated with superior treatment persistence but not with higher remission rates vedolizumab in patients with refractory Crohn’s disease: results from a multicent... by Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patrícia Sarlós, Ákos Iliás, Kata Szántó, Mariann Rutka, Anita Bálint, Ágnes Milassin, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas

    Published 2022-12-01
    Get full text
    Article
  11. 11
    Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome

    Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome by Anita Bálint, Klaudia Farkas, Orsolya Méhi, Bálint Kintses, Bálint Márk Vásárhelyi, Eszter Ari, Csaba Pál, Tamara Madácsy, József Maléth, Kata Judit Szántó, István Nagy, Mariann Rutka, Péter Bacsur, Diána Szűcs, Zoltán Szepes, Ferenc Nagy, Anna Fábián, Renáta Bor, Ágnes Milassin, Tamás Molnár

    Published 2020-10-01
    Get full text
    Article

Search Tools: